Adam Truby
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic Plasmodium falciparum sporozoite challenge in mice.
Journal: Frontiers in immunology
Published: January 17, 2026
Corrigendum to "Naturally acquired immune responses to alpha-gal in malaria endemic settings and pre-clinical efficacy testing with R21/MM" [Vaccine 68 (2025) 127897].
Journal: Vaccine
Published: November 16, 2025
BCG enables protection against malaria through adjuvanting an adenovirus-vectored vaccine.
Journal: NPJ vaccines
Published: October 14, 2025
Core-shell microcapsules compatible with routine injection enable prime/boost immunization against malaria with a single shot.
Journal: Science translational medicine
Published: June 25, 2025
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture.
Journal: iScience
Published: April 05, 2023
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.
Journal: EBioMedicine
Published: September 07, 2021
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.
Journal: Nature communications
Published: January 28, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026